Acthera Therapeutics ^Company

Acthera Therapeutics is an early-stage biotechnology company that is developing a nanotechnology-based platform for controlled and targeted drug delivery. Their Hard-Shelled Liposomes (HSLs) can be used for targeted drug release in various medical indications. The company has a clear vision and mission to transform medical therapy for the benefit of patients.